# Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors

> **NCT05547906** · PHASE1 · COMPLETED · sponsor: **MetaFines** · enrollment: 18 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** ASCA101

## Key facts

- **NCT ID:** NCT05547906
- **Lead sponsor:** MetaFines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-08
- **Primary completion:** 2024-02-29
- **Final completion:** 2024-02-29
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05547906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05547906, "Evaluation of the Safety and Efficacy of ASCA101 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05547906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*